NeuroScientific Biopharmaceuticals Limited (NSB.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 324.21 Thousand AUD | 130.34% |
| 2023 | -1.06 Million AUD | 89.76% |
| 2022 | -10.43 Million AUD | -228.38% |
| 2021 | -3.17 Million AUD | -10.78% |
| 2020 | -2.86 Million AUD | -72.92% |
| 2019 | -1.65 Million AUD | -78.11% |
| 2018 | -931.42 Thousand AUD | -256.71% |
| 2017 | -261.11 Thousand AUD | -152.56% |
| 2016 | -103.38 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.23 Million AUD | 0.0% |
| 2024 Q4 | 1.55 Million AUD | 0.0% |
| 2024 FY | 324.21 Thousand AUD | 130.34% |
| 2023 Q4 | 1.99 Million AUD | 0.0% |
| 2023 FY | -1.06 Million AUD | 89.76% |
| 2023 Q2 | -3.05 Million AUD | 0.0% |
| 2022 Q2 | -5.73 Million AUD | 0.0% |
| 2022 FY | -10.43 Million AUD | -228.38% |
| 2022 Q4 | -4.7 Million AUD | 0.0% |
| 2021 FY | -3.17 Million AUD | -10.78% |
| 2021 Q2 | -1.22 Million AUD | 0.0% |
| 2021 Q4 | -1.95 Million AUD | 0.0% |
| 2020 Q4 | -978.41 Thousand AUD | 0.0% |
| 2020 FY | -2.86 Million AUD | -72.92% |
| 2020 Q2 | -1.89 Million AUD | 0.0% |
| 2019 Q4 | -817.13 Thousand AUD | 0.0% |
| 2019 Q2 | -841.77 Thousand AUD | 0.0% |
| 2019 FY | -1.65 Million AUD | -78.11% |
| 2018 Q2 | -324.74 Thousand AUD | 0.0% |
| 2018 FY | -931.42 Thousand AUD | -256.71% |
| 2018 Q4 | -606.67 Thousand AUD | 0.0% |
| 2017 FY | -261.11 Thousand AUD | -152.56% |
| 2017 Q2 | -153.11 Thousand AUD | -100.0% |
| 2017 Q4 | -108 Thousand AUD | 0.0% |
| 2017 Q1 | -76.55 Thousand AUD | 0.0% |
| 2016 FY | -103.38 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | 106.025% |
| Acrux Limited | -5.8 Million AUD | 105.59% |
| Amplia Therapeutics Limited | -4.5 Million AUD | 107.199% |
| Biome Australia Limited | -1.67 Million AUD | 119.411% |
| BTC Health Limited | 1.05 Million AUD | 69.278% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 102.588% |
| CSL Limited | 2.64 Billion AUD | 99.988% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 100.766% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 99.09% |
| Noxopharm Limited | -3.57 Million AUD | 109.061% |
| PharmAust Limited | -9.03 Million AUD | 103.589% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 105.085% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 103.936% |
| PYC Therapeutics Limited | -37.72 Million AUD | 100.859% |
| Race Oncology Limited | -13.81 Million AUD | 102.346% |
| Starpharma Holdings Limited | -8.16 Million AUD | 103.971% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 95.345% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 102.338% |
| Memphasys Limited | -4.44 Million AUD | 107.299% |
| Nyrada Inc. | -1.38 Million AUD | 123.388% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | 122.34% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 93.778% |
| Bio-Gene Technology Limited | -2.4 Million AUD | 113.457% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 100.887% |
| Patrys Limited | -3.53 Million AUD | 109.161% |
| Dimerix Limited | -17.07 Million AUD | 101.899% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 99.794% |
| Orthocell Limited | -7.18 Million AUD | 104.515% |
| Imugene Limited | -149.68 Million AUD | 100.217% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 103.327% |
| Immutep Limited | -39.89 Million AUD | 100.813% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 103.707% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 101.695% |
| Nanollose Limited | -1.15 Million AUD | 128.032% |
| Invex Therapeutics Ltd | -1.64 Million AUD | 119.747% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | 111.319% |
| Biotron Limited | -3.43 Million AUD | 109.434% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 100.676% |
| Tissue Repair Ltd | -4.13 Million AUD | 107.835% |
| AnteoTech Limited | -8.88 Million AUD | 103.651% |
| Hexima Limited | -933.87 Thousand AUD | 134.717% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 100.553% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 101.836% |
| Avecho Biotechnology Limited | -3.43 Million AUD | 109.434% |
| Actinogen Medical Limited | -13.04 Million AUD | 102.485% |
| Immuron Limited | -6.93 Million AUD | 104.674% |
| Argenica Therapeutics Limited | -5.47 Million AUD | 105.917% |